Target intelligence / Profile preview

Vesicular stomatitis virus glycoprotein (VSV-G)

Target
VSV-G
Molecular classification
Viral fusion protein (Class III fusion protein), Envelope glycoprotein, Receptor-binding viral protein, Other: Not a human protein, but a viral protein often used in biotechnology
01

Overview

Vesicular stomatitis virus glycoprotein (VSV-G) is the surface envelope glycoprotein of vesicular stomatitis virus (VSV), a rhabdovirus. VSV-G is a class III viral fusion protein responsible for mediating both receptor recognition (binding to cell surface molecules) and low pH-triggered membrane fusion, thereby enabling the virus to enter host cells. The protein functions as a trimer on the viral envelope and undergoes reversible, pH-dependent conformational changes during membrane fusion. VSV-G is notable in biotechnology, where it is widely used to pseudotype lentiviral and other viral vectors to broaden tropism and improve stability of gene delivery systems. It is not a human target nor a conventional drug target, but is highly relevant as a tool and sometimes as a safety concern in gene therapy and vaccine development.

Other names
VSV G proteinVSV-GVesicular stomatitis virus G proteinVSV envelope glycoprotein
02

Mechanism of action

For VSV-G pseudotyped vectors: mediates entry of recombinant vectors into target cells by binding broadly to cell surface phosphatidylserine and other receptors, then triggers membrane fusion upon acidification in endosomes. For potential antivirals: would block receptor binding or membrane fusion.

03

Biological functions

Mediates viral attachment (receptor recognition at the host cell surface)Triggers membrane fusion in a pH-dependent manner, allowing viral entryDrives virus assembly and budding via membrane microdomain organizationOften used to pseudotype viral vectors for gene delivery in research and therapy
04

Disease associations

Infection (as part of vesicular stomatitis virus and related recombinant vectors)Other: Used in cancer therapy, vaccine vectors, and gene therapy as a delivery vehicle (not as a disease-causing agent directly)
05

Safety considerations

Immunogenicity—induces strong immune responses when delivered in vivoPossibility of off-target transduction in unintended tissues/cells in gene therapy settingsBiosafety concerns over replication-competent virus production when using vectors
06

Interacting drugs

None approved for targeting VSV-G directly in clinical practice. However, broad-spectrum antiviral agents or fusion inhibitors targeting viral glycoproteins might interact experimentally.
07

Biomarkers

None in approved patient use. VSV-G presence used as a marker of transduction/infection in research settings.

Beyond the preview

Go deeper on Vesicular stomatitis virus glycoprotein (VSV-G).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vesicular stomatitis virus glycoprotein (VSV-G).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call